The Hormonal Regulation of Calcium Metabolism

Seldin and Geibisch's The Kidney

Volumn 2, Issue , 2013, Pages 2249-2272

  Tebben, Peter J ^a   Kumar, Rajiv ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84883982479     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-0-12-381462-3.00065-3     Document Type: Chapter

References (387)

1. Adams J.S., Clemens T.L., Parrish J.A., Holick M.F. Vitamin-D synthesis and metabolism after ultraviolet irradiation of normal and vitamin-D-deficient subjects. N Engl J Med 1982, 306:722-725.
2. Adams N.D., Garthwaite T.L., Gray R.W., Hagen T.C., Lemann J. The interrelationships among prolactin, 1,25-dihydroxyvitamin D, and parathyroid hormone in humans. J Clin Endocrinol Metab 1979, 49:628-630.
3. Adams N.D., Gray R.W., Lemann J. The calciuria of increased fixed acid production in humans: evidence against a role for parathyroid hormone and 1,25(OH)2-vitamin D. Calcif Tissue Int 1979, 28:233-238.
4. 3 loading and dietary calcium deprivation on plasma 1,25-dihydroxyvitamin D concentrations in healthy adults. J Clin Endocrinol Metab 1979, 48:1008-1016.
5. Akeno N., Matsunuma A., Maeda T., Kawane T., Horiuchi N. Regulation of vitamin D-1alpha-hydroxylase and -24-hydroxylase expression by dexamethasone in mouse kidney. J Endocrinol 2000, 164:339-348.
6. Albert B., Johnson A., Lewis J., Raff M., Roberts K., Walter P. Molecular biology of the cell 2002, Garland Science, Taylor and Francis Group, New York.
7. Alvarez-Hernandez D., Naves M., Santamaria I., Menarguez J., Torregrosa V., Cannata J. Response of parathyroid glands to calcitriol in culture: is this response mediated by the genetic polymorphisms in vitamin D receptor?. Kidney Int Suppl 2003, S19-S22.
8. Anast C.S., Winnacker J.L., Forte L.R., Burns T.W. Impaired release of parathyroid hormone in magnesium deficiency. J Clin Endocrinol Metab 1976, 42:707-717.
9. Araya Z., Hosseinpour F., Bodin K., Wikvall K. Metabolism of 25-hydroxyvitamin D3 by microsomal and mitochondrial vitamin D3 25-hydroxylases (CYP2D25 and CYP27A1): a novel reaction by CYP27A1. Biochim Biophys Acta 2003, 1632:40-47.
10. Armbrecht H.J., Boltz M.A., Bruns M.E. Effect of age and dietary calcium on intestinal calbindin D-9k expression in the rat. Arch Biochem Biophys 2003, 420:194-200.
11. Armbrecht H.J., Boltz M.A., Christakos S., Bruns M.E. Capacity of 1,25-dihydroxyvitamin D to stimulate expression of calbindin D changes with age in the rat. Arch Biochem Biophys 1998, 352:159-164.
12. Armbrecht H.J., Boltz M.A., Kumar V.B. Intestinal plasma membrane calcium pump protein and its induction by 1,25(OH)(2)D(3) decrease with age. Am J Physiol 1999, 277:G41-G47.
13. Armbrecht H.J., Boltz M.A., Wongsurawat N. Expression of plasma membrane calcium pump mRNA in rat intestine: effect of age and 1,25-dihydroxyvitamin D. Biochim Biophys Acta 1994, 1195:110-114.
14. Armbrecht H.J., Hodam T.L., Boltz M.A. Hormonal regulation of 25-hydroxyvitamin D3-1alpha-hydroxylase and 24-hydroxylase gene transcription in opossum kidney cells. Arch Biochem Biophys 2003, 409:298-304.
15. Askew F., Bourdillon R., Bruce H., Jenkins R., Webster T. The distillation of vitamin D. Proc R Soc B 1931, 107:76-90.
16. 2+ channels in renal epithelial cells by parathyroid hormone. Nature 1990, 347:388-391.
17. Bar A., Shani M., Fullmer C.S., Brindak M.E., Striem S. Modulation of chick intestinal and renal calbindin gene expression by dietary vitamin D3, 1,25-dihydroxyvitamin D3, calcium and phosphorus. Mol Cell Endocrinol 1990, 72:23-31.
18. Barley N.F., Prathalingam S.R., Zhi P., Legon S., Howard A., Walters J.R. Factors involved in the duodenal expression of the human calbindin-D9k gene. Biochem J 1999, 341:491-500.
19. Barry E.L., Gesek F.A., Yu A.S., Lytton J., Friedman P.A. Distinct calcium channel isoforms mediate parathyroid hormone and chlorothiazide-stimulated calcium entry in transporting epithelial cells. J Membr Biol 1998, 161:55-64.
20. Berndt T., Craig T.A., Bowe A.E., Vassiliadis J., Reczek D., Finnegan R., et al. Secreted frizzled-related protein 4 is a potent tumor-derived phosphaturic agent. J Clin Invest 2003, 112:785-794.
21. Bhattacharyya M.H., DeLuca H.F. Subcellular location of rat liver calciferol-25-hydroxylase. Arch Biochem Biophys 1974, 160:58-62.
22. Bianda T., Glatz Y., Rbouillon R., Froesch E.R., Schmid C. Effects of short-term insulin-like growth factor-I (IGF-I) or growth hormone (GH) treatment on bone metabolism and on production of 1,25-dihydroxycholecalciferol in GH-deficient adults. J Clin Endocrinol Metab 1998, 83:81-87.
23. Bikle D.D., Nemanic M.K., Gee E., Elias P. 1,25-Dihydroxyvitamin D3 production by human keratinocytes. Kinetics and regulation. J Clin Invest 1986, 78:557-566.
24. Bilezikian J.P., Canfield R.E., Jacobs T.P., Polay J.S., D'Adamo A.P., Eisman J.A., et al. Response of 1alpha, 25-dihydroxyvitamin D3 to hypocalcemia in human subjects. N Engl J Med 1978, 299:437-441.
25. 2+ transport in primary cultures of rabbit kidney CCD: stimulation by 1,25-dihydroxyvitamin D3 and PTH. Am J Physiol 1991, 261:F799-F807.
26. Biner H.L., Arpin-Bott M.P., Loffing J., Wang X., Knepper M., Hebert S.C., et al. Human cortical distal nephron: distribution of electrolyte and water transport pathways. J Am Soc Nephrol 2002, 13:836-847.
27. Bjorkhem I., Hansson R., Holmberg I., Wikvall K. 25-Hydroxylation of vitamin D3 by a reconstituted system from rat liver microsomes. Biochem Biophys Res Commun 1979, 90:615-622.
28. Bjorkhem I., Holmberg I. Assay and properties of a mitochondrial 25-hydroxylase active on vitamine D3. J Biol Chem 1978, 253:842-849.
29. Bland R., Walker E.A., Hughes S.V., Stewart P.M., Hewison M. Constitutive expression of 25-hydroxyvitamin D3-1alpha-hydroxylase in a transformed human proximal tubule cell line: evidence for direct regulation of vitamin D metabolism by calcium. Endocrinology 1999, 140:2027-2034.
30. Bland R., Zehnder D., Hewison M. Expression of 25-hydroxyvitamin D3-1alpha-hydroxylase along the nephron: new insights into renal vitamin D metabolism. Curr Opin Nephrol Hypertens 2000, 9:17-22.
31. Bland R., Zehnder D., Hughes S.V., Ronco P.M., Stewart P.M., Hewison M. Regulation of vitamin D-1alpha-hydroxylase in a human cortical collecting duct cell line. Kidney Int 2001, 60:1277-1286.
32. Blunt J.W., DeLuca H.F. The synthesis of 25-hydroxycholecalciferol. A biologically active metabolite of vitamin D3. Biochemistry (Mosc) 1969, 8:671-675.
33. Blunt J.W., DeLuca H.F., Schnoes H.K. 25-hydroxycholecalciferol. A biologically active metabolite of vitamin D3. Biochemistry (Mosc) 1968, 7:3317-3322.
34. Blunt J.W., Tanaka Y., DeLuca H.F. The biological activity of 25-hydroxycholecalciferol, a metabolite of vitamin D3. Proc Natl Acad Sci USA 1968, 61:1503-1506.
35. Bolt M.J., Wei M., Sitrin M.D., Chun Li Y, Cao L.P. Regulation of calbindin-D9k expression by 1,25-dihydroxyvitamin D3 and parathyroid hormone in mouse primary renal tubular cells. Arch Biochem Biophys 2002, 400:118-124.
36. Borke J.L., Caride A., Verma A.K., Penniston J.T., Kumar R. Plasma membrane calcium pump and 28-kDa calcium binding protein in cells of rat kidney distal tubules. Am J Physiol 1989, 257:F842-F849.
37. ++ adenosine triphosphatase pump recognize an epitope in the basolateral membrane of human kidney distal tubule cells. J Clin Invest 1987, 80:1225-1231.
38. ++ ATPase and vitamin D-dependent 28-kDa-calcium binding protein. Kidney Int 1988, 34:262-267.
39. Borke J.L., Penniston J.T., Kumar R. Recent advances in calcium transport by the kidney. Semin Nephrol 1990, 10:15-23.
40. Bouhtiauy I., Lajeunesse D., Brunette M.G. The mechanism of parathyroid hormone action on calcium reabsorption by the distal tubule. Endocrinology 1991, 128:251-258.
41. Bouillon R., Muls E., De Moor P. Influence of thyroid function on the serum concentration of 1,25-dihydroxyvitamin D3. J Clin Endocrinol Metab 1980, 51:793-797.
42. Bouillon R., Van Cromphaut S., Carmeliet G. Intestinal calcium absorption: molecular vitamin D mediated mechanisms. J Cell Biochem 2003, 88:332-339.
43. 3: Nicolaysen's endogenous factor. Proceeding of the international symposium on endocrinology 1972, 468-476. Heinemann, London. S. Taylor (Ed.).
44. Brenza H.L., DeLuca H.F. Regulation of 25-hydroxyvitamin D3 1alpha-hydroxylase gene expression by parathyroid hormone and 1,25-dihydroxyvitamin D3. Arch Biochem Biophys 2000, 381:143-152.
45. Brenza H.L., Kimmel-Jehan C., Jehan F., Shinki T., Wakino S., Anazawa H., et al. Parathyroid hormone activation of the 25-hydroxyvitamin D3-1alpha-hydroxylase gene promoter. Proc Natl Acad Sci USA 1998, 95:1387-1391.
46. Brown A.J., Zhong M., Finch J., Ritter C., Slatopolsky E. The roles of calcium and 1,25-dihydroxyvitamin D3 in the regulation of vitamin D receptor expression by rat parathyroid glands. Endocrinology 1995, 136:1419-1425.
47. 2+ and other ions as extracellular (first) messengers. Physiol Rev 1991, 71:371-411.
48. Brun P., Dupret J.M., Perret C., Thomasset M., Mathieu H. Vitamin D-dependent calcium-binding proteins (CaBPs) in human fetuses: comparative distribution of 9K CaBP mRNA and 28K CaBP during development. Pediatr Res 1987, 21:362-367.
49. Brustad M., Alsaker E., Engelsen O., Aksnes L., Lund E. Vitamin D status of middle-aged women at 65-71 degrees N in relation to dietary intake and exposure to ultraviolet radiation. Public Health Nutr 2004, 7:327-335.
50. Buchan A.M., Squires P.E., Ring M., Meloche R.M. Mechanism of action of the calcium-sensing receptor in human antral gastrin cells.[see comment]. Gastroenterology 2001, 120:1128-1139.
51. Buckle R.M., Care A.D., Cooper C.W., Gitelman H.J. The influence of plasma magnesium concentration on parathyroid hormone secretion. J Endocrinol 1968, 42:529-534.
52. Burgos-Trinidad M., Ismail R., Ettinger R.A., Prahl J.M., DeLuca H.F. Immunopurified 25-hydroxyvitamin D 1 alpha-hydroxylase and 1,25-dihydroxyvitamin D 24-hydroxylase are closely related but distinct enzymes. J Biol Chem 1992, 267:3498-3505.
53. Butler S.J., Payne R.B., Gunn I.R., Burns J., Paterson C.R. Correlation between serum ionised calcium and serum albumin concentrations in two hospital populations. Br Med J (Clin Res Ed) 1984, 289:948-950.
54. Cai Q., Hodgson S.F., Kao P.C., Lennon V.A., Klee G.G., Zinsmiester A.R., et al. Brief report: inhibition of renal phosphate transport by a tumor product in a patient with oncogenic osteomalacia.[see comment]. N Engl J Med 1994, 330:1645-1649.
55. Calvo M.S., Heath H. Acute effects of oral phosphate-salt ingestion on serum phosphorus, serum ionized calcium, and parathyroid hormone in young adults. Am J Clin Nutr 1988, 47:1025-1029.
56. Calvo M.S., Kumar R., Heath H. Elevated secretion and action of serum parathyroid hormone in young adults consuming high phosphorus, low calcium diets assembled from common foods. J Clin Endocrinol Metab 1988, 66:823-829.
57. Canaff L., Petit J.L., Kisiel M., Watson P.H., Gascon-Barre M., Hendy G.N. Extracellular calcium-sensing receptor is expressed in rat hepatocytes. Coupling to intracellular calcium mobilization and stimulation of bile flow. J Biol Chem 2001, 276:4070-4079.
58. Caride A.J., Chini E.N., Homma S., Dousa T.P., Penniston J.T. mRNAs coding for the calcium-sensing receptor along the rat nephron: effect of a low-phosphate diet. Kidney Blood Press Res 1998, 21:305-309.
59. 2+ pump isoform 3 in rat thin descending loop of Henle. Am J Physiol 1995, 269:F681-F685.
60. Caride A.J., Filoteo A.G., Enyedi A., Verma A.K., Penniston J.T. Detection of isoform 4 of the plasma membrane calcium pump in human tissues by using isoform-specific monoclonal antibodies. Biochem J 1996, 316:353-359.
61. Carre M., Ayigbede O., Miravet L., Rasmussen H. The effect of Prednisolone upon the metabolism and action of 25-hydroxy-and 1,25-dihydroxyvitamin D3. Proc Natl Acad Sci USA 1974, 71:2996-3000.
62. Castillo L., Tanaka Y., DeLuca H.F., Sunde M.L. The stimulation of 25-hydroxyvitamin D3-1 alpha-hydroxylase by estrogen. Arch Biochem Biophys 1977, 179:211-217.
63. Cetani F., Lemmi M., Cervia D., Borsari S., Cianferotti L., Pardi E., et al. Identification and functional characterization of loss-of-function mutations of the calcium-sensing receptor in four Italian kindreds with familial hypocalciuric hypercalcemia. Eur J Endocrinol 2009, 160:481-489.
64. Chang W., Tu C., Chen T.H., Komuves L., Oda Y., Pratt S.A., et al. Expression and signal transduction of calcium-sensing receptors in cartilage and bone. Endocrinology 1999, 140:5883-5893.
65. Chattopadhyay N. Biochemistry, physiology and pathophysiology of the extracellular calcium-sensing receptor. Int J Biochem Cell Biol 2000, 32:789-804.
66. 2+-sensing receptor in rat intestine. Am J Physiol 1998, 274:G122-G130.
67. Chattopadhyay N., Mithal A., Brown E.M. The calcium-sensing receptor: a window into the physiology and pathophysiology of mineral ion metabolism. Endocr Rev 1996, 17:289-307.
68. Chattopadhyay N., Ye C., Singh D.P., Kifor O., Vassilev P.M., Shinohara T., et al. Expression of extracellular calcium-sensing receptor by human lens epithelial cells. Biochem Biophys Res Commun 1997, 233:801-805. [erratum appears in Biochem Biophys Res Commun. 1997 Aug 18;237(2):481].
69. Chen J., Zhang J., Lin S. Down-regulation of PTH/PTHrP receptor in the kidney of patients with renal impairment. Chin Med J (Engl) 1998, 111:24-27.
70. Chen M.L., Boltz M., Christakos S., Armbrecht H.J. Age-related alterations in calbindin-D28K induction by 1,25-dihydroxyvitamin D3 in primary cultures of rat renal tubule cells. Endocrinology 1992, 130:3295-3300.
71. Cheng I., Klingensmith M.E., Chattopadhyay N., Kifor O., Butters R.R., Soybel D.I., et al. Identification and localization of the extracellular calcium-sensing receptor in human breast. J Clin Endocrinol Metab 1998, 83:703-707.
72. Cheng I., Qureshi I., Chattopadhyay N., Qureshi A., Butters R.R., Hall A.E., et al. Expression of an extracellular calcium-sensing receptor in rat stomach. Gastroenterology 1999, 116:118-126.
73. Chick H., Palzell E., Hume E. Studies of rickets in Vienna 1919-1922. Medical research council 1923, [Special Report No 77], Medical Research Council, Vienna.
74. Clemens T.L., Adams J.S., Henderson S.L., Holick M.F. Increased skin pigment reduces the capacity of skin to synthesise vitamin D3. Am J Clin Nutr 1994, 60:619-630.
75. Clemens T.L., McGlade S.A., Garrett K.P., Craviso G.L., Hendy G.N. Extracellular calcium modulates vitamin D-dependent calbindin-D28K gene expression in chick kidney cells. Endocrinology 1989, 124:1582-1584.
76. Coltrera M.D., Potts J.T., Rosenblatt M. Identification of a renal receptor for parathyroid hormone by photoaffinity radiolabeling using a synthetic analogue. J Biol Chem 1981, 256:10555-10559.
77. Condamine L., Menaa C., Vrtovsnik F., Vztovsnik F., Friedlander G., Garabedian M. Local action of phosphate depletion and insulin-like growth factor 1 on in vitro production of 1,25-dihydroxyvitamin D by cultured mammalian kidney cells. J Clin Invest 1994, 94:1673-1679. [erratum appears in J Clin Invest 1995 Jan;95(1):following 434].
78. Conigrave A.D., Mun H.C., Delbridge L., Quinn S.J., Wilkinson M., Brown E.M. L-amino acids regulate parathyroid hormone secretion. J Biol Chem 2004, 279:38151-38159.
79. Cornish J., Callon K.E., Bava U., Kamona S.A., Cooper G.J., Reid I.R. Effects of calcitonin, amylin, and calcitonin gene-related peptide on osteoclast development. Bone 2001, 29:162-168.
80. Craviso G.L., Garrett K.P., Clemens T.L. 1,25-Dihydroxyvitamin D3 induces the synthesis of vitamin D-dependent calcium-binding protein in cultured chick kidney cells. Endocrinology 1987, 120:894-902.
81. D'Souza-Li L., Canaff L., Janicic N., Cole D.E., Hendy G.N. An acceptor splice site mutation in the calcium-sensing receptor (CASR) gene in familial hypocalciuric hypercalcemia and neonatal severe hyperparathyroidism. Hum Mutat 2001, 18:411-421.
82. D'Souza-Li L., Yang B., Canaff L., Bai M., Hanley D.A., Bastepe M., et al. Identification and functional characterization of novel calcium-sensing receptor mutations in familial hypocalciuric hypercalcemia and autosomal dominant hypocalcemia. J Clin Endocrinol Metab 2002, 87:1309-1318.
83. Darwish H.M., DeLuca H.F. Identification of a 1,25-dihydroxyvitamin D3-response element in the 5'-flanking region of the rat calbindin D-9k gene. Proc Natl Acad Sci USA 1992, 89:603-607.
84. De Beur S.M., Finnegan R.B., Vassiliadis J., Cook B., Barberio D., Estes S., et al. Tumors associated with oncogenic osteomalacia express genes important in bone and mineral metabolism. J Bone Miner Res 2002, 17:1102-1110.
85. de Vernejoul M.C., Horowitz M., Demignon J., Neff L., Baron R. Bone resorption by isolated chick osteoclasts in culture is stimulated by murine spleen cell supernatant fluids (osteoclast-activating factor) and inhibited by calcitonin and prostaglandin E2. J Bone Miner Res 1988, 3:69-80.
86. DeLuca H.F. Historical perspective. Vitamin D 2005, 3-14. Academic Press, Boston. 2nd ed. D. Feldman, J.W. Pike, F.H. Glorieux (Eds.).
87. DeLuca H.F., Schnoes H.K. Metabolism and mechanism of action of vitamin D. Annu Rev Biochem 1976, 45:631-666.
88. DeLuca H.F., Schnoes H.K. Vitamin D: recent advances. Annu Rev Biochem. 1983, 52:411-439.
89. Demay M.B., Kiernan M.S., DeLuca H.F., Kronenberg H.M. Sequences in the human parathyroid hormone gene that bind the 1,25-dihydroxyvitamin D3 receptor and mediate transcriptional repression in response to 1,25-dihydroxyvitamin D3. Proc Natl Acad Sci USA 1992, 89:8097-8101.
90. Dempster D.W., Hughes-Begos C.E., Plavetic-Chee K., Brandao-Burch A., Cosman F., Nieves J., et al. Normal human osteoclasts formed from peripheral blood monocytes express PTH type 1 receptors and are stimulated by PTH in the absence of osteoblasts. J Cell Biochem 2005, 95:139-148.
91. den Dekker E., Hoenderop J.G., Nilius B., Bindels R.J. The epithelial calcium channels, TRPV5 & TRPV6: from identification towards regulation. Cell Calcium. 2003, 33:497-507.
92. Diaz L., Arranz C., Avila E., Halhali A., Vilchis F., Larrea F. Expression and activity of 25-hydroxyvitamin D-1 alpha-hydroxylase are restricted in cultures of human syncytiotrophoblast cells from preeclamptic pregnancies. J Clin Endocrinol Metab 2002, 87:3876-3882.
93. Drezner M.K., Neelon F.A., Haussler M., McPherson H.T., Lebovitz H.E. 1,25-Dihydroxycholecalciferol deficiency: the probable cause of hypocalcemia and metabolic bone disease in pseudohypoparathyroidism. J Clin Endocrinol Metab 1976, 42:621-628.
94. Dusso A.S., Finch J., Brown A., Ritter C., Delmez J., Schreiner G., et al. Extrarenal production of calcitriol in normal and uremic humans. J Clin Endocrinol Metab 1991, 72:157-164.
95. Eastell R., Yergey A.L., Vieira N.E., Cedel S.L., Kumar R., Riggs B.L. Interrelationship among vitamin D metabolism, true calcium absorption, parathyroid function, and age in women: evidence of an age-related intestinal resistance to 1,25-dihydroxyvitamin D action. J Bone Miner Res 1991, 6:125-132.
96. Ebeling P.R., Yergey A.L., Vieira N.E., Burritt M.F., O'Fallon W.M., Kumar R., et al. Influence of age on effects of endogenous 1,25-dihydroxyvitamin D on calcium absorption in normal women. Calcif Tissue Int 1994, 55:330-334.
97. Edwards R.M., Contino L.C., Gellai M., Brooks D.P. Parathyroid hormone-1 receptor down-regulation in kidneys from rats with chronic renal failure. Pharmacology 2001, 62:243-247.
98. Ejima E., Fujiyama K., Kiriyama T., Ide A., Sera N., Tominaga T., et al. Parathyroidectomy for primary hyperparathyroidism induces positive uncoupling and increases bone mineral density in cancellous bones. Clin Endocrinol (Oxf) 2000, 52:203-209.
99. Eskildsen P.C., Lund B., Sorensen O.H., Bishop J.E., Norman A.W. Acromegaly and vitamin D metabolism: effect of bromocriptine treatment. J Clin Endocrinol Metab 1979, 49:484-486.
100. Esvelt R.P., Schnoes H.K., DeLuca H.F. Vitamin D3 from rat skins irradiated in vitro with ultraviolet light. Arch Biochem Biophys 1978, 188:282-286.
101. Eyles D.W., Smith S., Kinobe R., Hewison M., McGrath J.J. Distribution of the vitamin D receptor and 1 alpha-hydroxylase in human brain. J Chem Neuroanat 2005, 29:21-30.
102. Fatemi S., Ryzen E., Flores J., Endres D.B., Rude R.K. Effect of experimental human magnesium depletion on parathyroid hormone secretion and 1,25-dihydroxyvitamin D metabolism. J Clin Endocrinol Metab 1991, 73:1067-1072.
103. Favus M.J., Walling M.W., Kimberg D.V. Effects of 1,25-dihydroxycholecalciferol on intestinal calcium transport in cortisone-treated rats. J Clin Invest 1973, 52:1680-1685.
104. Feher J.J., Wasserman R.H. Intestinal calcium-binding protein and calcium absorption in cortisol-treated chicks: effects of vitamin D3 and 1,25-dihydroxyvitamin D3. Endocrinology 1979, 104:547-551.
105. Feldman R.S., Krieger N.S., Tashjian A.H. Effects of parathyroid hormone and calcitonin on osteoclast formation in vitro. Endocrinology 1980, 107:1137-1143.
106. Ferment O., Garnier P.E., Touitou Y. Comparison of the feedback effect of magnesium and calcium on parathyroid hormone secretion in man. J Endocrinol 1987, 113:117-122.
107. Finkelstein J.S., Hayes A., Hunzelman J.L., Wyland J.J., Lee H., Neer R.M. The effects of parathyroid hormone, alendronate, or both in men with osteoporosis. N Engl J Med 2003, 349:1216-1226.
108. Firsov D., Bellanger A.C., Marsy S., Elalouf J.M. Quantitative RT-PCR analysis of calcitonin receptor mRNAs in the rat nephron. Am J Physiol 1995, 269:F702-F709.
109. Fogh-Andersen N., Bjerrum P.J., Siggaard-Andersen O. Ionic binding, net charge, and Donnan effect of human serum albumin as a function of pH. Clin Chem 1993, 39:48-52.
110. Fraher L.J., Hendy G.N., Chung U.I., Kisiel M., Natale B.V., Hodsman A.B., et al. Nuclear localization of the type 1 PTH/PTHrP receptor in rat tissues. J Bone Miner Res 2000, 15:1033-1044.
111. Fraser D.R., Kodicek E. Regulation of 25-hydroxycholecalciferol-1-hydroxylase activity in kidney by parathyroid hormone. Nature New Biol 1973, 241:163-166.
112. Fraser D.R., Kodicek E. Unique biosynthesis by kidney of a biological active vitamin D metabolite. Nature 1970, 228:764-766.
113. Freichel M., Zink-Lorenz A., Holloschi A., Hafner M., Flockerzi V., Raue F. Expression of a calcium-sensing receptor in a human medullary thyroid carcinoma cell line and its contribution to calcitonin secretion. Endocrinology 1996, 137:3842-3848.
114. Friedman P.A., Coutermarsh B.A., Kennedy S.M., Gesek F.A. Parathyroid hormone stimulation of calcium transport is mediated by dual signaling mechanisms involving protein kinase A and protein kinase C. Endocrinology 1996, 137:13-20.
115. Friedrich M., Diesing D., Cordes T., Fischer D., Becker S., Chen T.C., et al. Analysis of 25-hydroxyvitamin D3-1alpha-hydroxylase in normal and malignant breast tissue. Anticancer Res 2006, 26:2615-2620.
116. Fudge N.J., Kovacs C.S. Physiological studies in heterozygous calcium sensing receptor (CaSR) gene-ablated mice confirm that the CaSR regulates calcitonin release in vivo. BMC Physiology 2004, 4:5.
117. Gagnon A.M., Simboli-Campbell M., Welsh J.E. Induction of calbindin D-28K in madin-darby bovine kidney cells by 1,25(OH)2D3. Kidney Int 1994, 45:95-102.
118. Garabedian M., Holick M.F., Deluca H.F., Boyle I.T. Control of 25-hydroxycholecalciferol metabolism by parathyroid glands. Proc Natl Acad Sci USA 1972, 69:1673-1676.
119. Garfia B., Canadillas S., Canalejo A., Luque F., Siendones E., Quesada M., et al. Regulation of parathyroid vitamin D receptor expression by extracellular calcium. J Am Soc Nephrol 2002, 13:2945-2952.
120. Garrett J.E., Tamir H., Kifor O., Simin R.T., Rogers K.V., Mithal A., et al. Calcitonin-secreting cells of the thyroid express an extracellular calcium receptor gene. Endocrinology 1995, 136:5202-5211.
121. Gartenberg F., Jacobs T.P., Shane E., Siris E., Staron R.B., McMahon D.J., et al. Increased bone mineral density after parathyroidectomy in primary hyperparathyroidism. J Clin Endocrinol Metab 1995, 80:729-734.
122. Gertner J.M., Horst R.L., Broadus A.E., Rasmussen H., Genel M. Parathyroid function and vitamin D metabolism during human growth hormone replacement. J Clin Endocrinol Metab 1979, 49:185-188.
123. Gesek F.A., Friedman P.A. Calcitonin stimulates calcium transport in distal convoluted tubule cells. Am J Physiol 1993, 264:F744-F751.
124. Gesek F.A., Friedman P.A. On the mechanism of parathyroid hormone stimulation of calcium uptake by mouse distal convoluted tubule cells. J Clin Invest 1992, 90:749-758.
125. Ghazarian J.G., DeLuca H.F. 25-Hydroxycholecalciferol-1-hydroxylase: a specific requirement for NADPH and a hemoprotein component in chick kidney mitochondria. Arch Biochem Biophys 1974, 160:63-72.
126. Ghazarian J.G., Jefcoate C.R., Knutson J.C., Orme-Johnson W.H., DeLuca H.F. Mitochondrial cytochrome p450. A component of chick kidney 25-hydrocholecalciferol-1alpha-hydroxylase. J Biol Chem 1974, 249:3026-3033.
127. Ghijsen W.E., Van Os C.H. 1 alpha, 25-Dihydroxy-vitamin D-3 regulates ATP-dependent calcium transport in basolateral plasma membranes of rat enterocytes. Biochim Biophys Acta 1982, 689:170-172.
128. Glendenning P., Ratajczak T., Dick I.M., Prince R.L. Calcitriol upregulates expression and activity of the 1b isoform of the plasma membrane calcium pump in immortalized distal kidney tubular cells. Arch Biochem Biophys 2000, 380:126-132.
129. Gordon C.M., DePeter K.C., Feldman H.A., Grace E., Emans S.J. Prevalence of vitamin D deficiency among healthy adolescents. Arch Pediatr Adolesc Med 2004, 158:531-537.
130. 2-vitamin D levels in humans: studies in healthy subjects in calcium-stone formers and in patients with primary hyperparathyroidism. J Clin Endocrinol Metab 1977, 45:299-306.
131. Habener J.F., Potts J.T. Relative effectiveness of magnesium and calcium on the secretion and biosynthesis of parathyroid hormone in vitro. Endocrinology 1976, 98:197-202.
132. Haddad J.G., Matsuoka L.Y., Hollis B.W., Hu Y.Z., Wortsman J. Human plasma transport of vitamin D after its endogenous synthesis. J Clin Invest 1993, 91:2552-2555.
133. Hall A.K., Norman A.W. Regulation of calbindin-D28K gene expression by 1,25-dihydroxyvitamin D3 in chick kidney. J Bone Miner Res 1990, 5:325-330.
134. Hanai H., Ishida M., Liang C.T., Sacktor B. Parathyroid hormone increases sodium/calcium exchange activity in renal cells and the blunting of the response in aging. J Biol Chem 1986, 261:5419-5425.
135. Hansson R., Holmberg I., Wikvall K. 25-Hydroxylation vitamin D3 and side chain hydroxylations of 5 beta-cholestane-3 alpha, 7 alpha, 12 alpha-triol by purified rabbit and rat liver microsomal cytochromes P-450. J Biol Chem 1981, 256:4345-4349.
136. Hatem S., Hoyaux D., De Decker V., Appelboom T., Pochet R., Steinfeld S. Expression of calcium-sensing receptor in human minor salivary glands. Clin Exp Rheumatol 2002, 20:576.
137. Haussler M.R., Myrtle J.F., Norman A.W. The association of a metabolite of vitamin D3 with intestinal mucosa chromatin in vivo. J Biol Chem 1968, 243:4055-4064.
138. Heaney R.P., Recker R.R. Determinants of endogenous fecal calcium in healthy women. J Bone Miner Res 1994, 9:1621-1627.
139. Hebden C., Smalt R., Chambers T., Pondel M.D. Multiple promoters regulate human calcitonin receptor gene expression. Biochem Biophys Res Commun 2000, 272:738-743.
140. Hemmingsen C., Staun M., Lewin E., Nielsen P.K., Olgaard K. Effect of vitamin D metabolites and analogs on renal and intestinal calbindin-D in the rat. Calcif Tissue Int 1996, 59:371-376.
141. Hemmingsen C., Staun M., Olgaard K. The effect of 1,25-vitamin D3 on calbindin-D and calcium-metabolic variables in the rat. Pharmacol Toxicol 1998, 82:118-121.
142. Hemmingsen C., Staun M., Olgaard K. Effects of magnesium on renal and intestinal calbindin-D. Miner Electrolyte Metab 1994, 20:265-273.
143. Hendy G.N., D'Souza-Li L., Yang B., Canaff L., Cole D.E. Mutations of the calcium-sensing receptor (CASR) in familial hypocalciuric hypercalcemia, neonatal severe hyperparathyroidism, and autosomal dominant hypocalcemia. Hum Mutat 2000, 16:281-296.
144. Henry H.L. Regulation of the hydroxylation of 25-hydroxyvitamin D3 in vivo and in primary cultures of chick kidney cells. J Biol Chem 1979, 254:2722-2729.
145. Henry H.L. Regulation of the synthesis of 1,25-dihydroxyvitamin D3 and 24,25-dihydroxyvitamin D3 int he kidney cell culture. Vitamin D: Basic and clinical aspects 1984, 152-174. Nijhoff, Boston. R. Kumar (Ed.).
146. Hess A., Weinstock M. Antirachitic properties imparted to lettuce and to growing wheat light ultraviolet irradiation. Proc Soc Exp Biol Med 1924, 22:5-6.
147. Higashi T., Shimada K., Toyo'oka T. Advances in determination of vitamin D related compounds in biological samples using liquid chromatography-mass spectrometry: a review. J Chromatogr B Analyt Technol Biomed Life Sci 2010, 878:1654-1661.
148. 2+ and 1,25-dihydroxyvitamin D3 in 25-hydroxyvitamin D3-1alpha-hydroxylase knockout mice. FASEB J 2002, 16:1398-1406.
149. 2+ reabsorption in rabbit kidney cortical collecting system is cAMP-independent and involves a phorbol ester-insensitive PKC isotype. Kidney Int 1999, 55:225-233.
150. Hoenderop J.G., Muller D., Van Der Kemp A.W., Hartog A., Suzuki M., Ishibashi K., et al. Calcitriol controls the epithelial calcium channel in kidney. J Am Soc Nephrol 2001, 12:1342-1349.
151. Hoenderop J.G., Nilius B., Bindels R.J. Epithelial calcium channels: from identification to function and regulation. Pflugers Arch 2003, 446:304-308.
152. Hoenderop J.G., Nilius B., Bindels R.J. Molecular mechanism of active Ca2+ reabsorption in the distal nephron. Annu Rev Physiol 2002, 64:529-549.
153. 2+ channel in 1, 25-dihydroxyvitamin D3-responsive epithelia. J Biol Chem 1999, 274:8375-8378.
154. 2+ transport proteins in 25-hydroxyvitamin D3-1alpha-hydroxylase knockout mice. Kidney Int 2004, 66:1082-1089.
155. Hofbauer L.C., Heufelder A.E. Clinical review 114: hot topic. The role of receptor activator of nuclear factor-kappaB ligand and osteoprotegerin in the pathogenesis and treatment of metabolic bone diseases. J Clin Endocrinol Metab 2000, 85:2355-2363.
156. Hofbauer L.C., Heufelder A.E. Role of receptor activator of nuclear factor-kappaB ligand and osteoprotegerin in bone cell biology. J Mol Med 2001, 79:243-253.
157. Holick M.F. The cutaneous photosynthesis of previtamin D3: a unique photoendocrine system. J Invest Dermatol 1981, 77:51-58.
158. Holick M.F., Garabedian M., DeLuca H.F. 1,25-dihydroxycholecalciferol: metabolite of vitamin D3 active on bone in anephric rats. Science 1972, 176:1146-1147.
159. Holick M.F., MacLaughlin J.A., Clark M.B., Holick S.A., Potts J.T., Anderson R.R., et al. Photosynthesis of previtamin D3 in human skin and the physiologic consequences. Science 1980, 210:203-205.
160. Holick M.F., Schnoes H.K., DeLuca H.F. Identification of 1,25-dihydroxycholecalciferol, a form of vitamin D3 metabolically active in the intestine. Proc Natl Acad Sci USA 1971, 68:803-804.
161. Holick M.F., Schnoes H.K., DeLuca H.F., Suda T., Cousins R.J. Isolation and identification of 1,25-dihydroxycholecalciferol. A metabolite of vitamin D active in intestine. Biochemistry (Mosc) 1971, 10:2799-2804.
162. Holmberg I., Berlin T., Ewerth S., Bjorkhem I. 25-Hydroxylase activity in subcellular fractions from human liver. Evidence for different rates of mitochondrial hydroxylation of vitamin D2 and D3. Scand J Clin Lab Invest 1986, 46:785-790.
163. Holmberg I., Kristiansen T., Sturen M. Determination of 25-hydroxyvitamin D3 in serum by high performance liquid chromatography and isotope dilution-mass spectrometry. Scand J Clin Lab Invest 1984, 44:275-282.
164. Hoppener J.W., Steenbergh P.H., Zandberg J., Bakker E., Pearson P.L., Geurts van Kessel A.H., et al. Localization of the polymorphic human calcitonin gene on chromosome 11. Hum Genet 1984, 66:309-312.
165. Horst R.L., Shepard R.M., Jorgensen N.A., DeLuca H.F. The determination of the vitamin D metabolites on a single plasma sample: changes during
166. Horwood N.J., Elliott J., Martin T.J., Gillespie M.T. Osteotropic agents regulate the expression of osteoclast differentiation factor and osteoprotegerin in osteoblastic stromal cells. Endocrinology 1998, 139:4743-4746.
167. Hosseinpour F., Ibranovic I., Tang W., Wikvall K. 25-Hydroxylation of vitamin D3 in primary cultures of pig hepatocytes: evidence for a role of both CYP2D25 and CYP27A1. Biochem Biophys Res Commun 2003, 303:877-883.
168. House M.G., Kohlmeier L., Chattopadhyay N., Kifor O., Yamaguchi T., Leboff M.S., et al. Expression of an extracellular calcium-sensing receptor in human and mouse bone marrow cells. J Bone Miner Res 1997, 12:1959-1970.
169. Howard A., Legon S., Spurr N.K., Walters J.R. Molecular cloning and chromosomal assignment of human calbindin-D9k. Biochem Biophys Res Commun 1992, 185:663-669.
170. Howard A., Legon S., Walters J.R. Human and rat intestinal plasma membrane calcium pump isoforms. Am J Physiol 1993, 265:G917-G925.
171. Howard A., Legon S., Walters J.R. Plasma membrane calcium pump expression in human placenta and small intestine. Biochem Biophys Res Commun 1992, 183:499-505.
172. Howard G.A., Turner R.T., Sherrard D.J., Baylink D.J. Human bone cells in culture metabolize 25-hydroxyvitamin D3 to 1,25-dihydroxyvitamin D3 and 24,25-dihydroxyvitamin D3. J Biol Chem 1981, 256:7738-7740.
173. Huang Y.C., Christakos S. Modulation of rat calbindin-D28 gene expression by 1,25-dihydroxyvitamin D3 and dietary alteration. Mol Endocrinol 1988, 2:928-935. [erratum appears in Mol Endocrinol 1988;2:1236].
174. Huldshinsky K. Heilung von rachitis durch kunstliche hohensonne. Deut Med Wochschr 1919, 45:712-713.
175. Hurley D.L., Tiegs R.D., Wahner H.W., Heath H. Axial and appendicular bone mineral density in patients with long-term deficiency or excess of calcitonin. N Engl J Med 1987, 317:537-541.
176. Ikegame M., Rakopoulos M., Martin T.J., Moseley J.M., Findlay D.M. Effects of continuous calcitonin treatment on osteoclast-like cell development and calcitonin receptor expression in mouse bone marrow cultures. J Bone Miner Res 1996, 11:456-465.
177. Inaba M., Okuno S., Imanishi Y., Nishizawa Y., Morii H. Magnesium deficiency enhances secretion of parathyroid hormone in normal and 5/6-nephrectomized uremic rats. J Endocrinol Invest 1992, 15:135-142.
178. Iqbal S.J., Giles M., Ledger S., Nanji N., Howl T. Need for albumin adjustments of urgent total serum calcium. Lancet 1988, 2:1477-1478.
179. Itami A., Kato M., Komoto I., Doi R., Hosotani R., Shimada Y., et al. Human gastrinoma cells express calcium-sensing receptor. Life Sci 2001, 70:119-129.
180. Jastrup B., Mosekilde L., Melsen F., Lund B., Sorensen O.H. Serum levels of vitamin D metabolites and bone remodelling in hyperthyroidism. Metabolism 1982, 31:126-132.
181. Jobert A.S., Fernandes I., Turner G., Coureau C., Prie D., Nissenson R.A., et al. Expression of alternatively spliced isoforms of the parathyroid hormone (PTH)/PTH-related peptide receptor messenger RNA in human kidney and bone cells. Mol Endocrinol 1996, 10:1066-1076.
182. Johnson M.A., Davey A., Park S., Hausman D.B., Poon L.W., Georgia Centenarian S. Age, race and season predict vitamin D status in African American and white octogenarians and centenarians. J Nutr Health Aging 2008, 12:690-695.
183. Jonsson K.B., Zahradnik R., Larsson T., White K.E., Sugimoto T., Imanishi Y., et al. Fibroblast growth factor 23 in oncogenic osteomalacia and X-linked hypophosphatemia.[see comment]. N Engl J Med 2003, 348:1656-1663.
184. Juppner H., Hesch R.D. Parathormone receptor binding and the influence of membrane degradation of the hormone. J Immunoassay 1980, 1:39-55.
185. Juttmann J.R., Visser T.J., Buurman C., de Kam E., Birkenhager J.C. Seasonal fluctuations in serum concentrations of vitamin D metabolites in normal subjects. Br Med J (Clin Res Ed) 1981, 282:1349-1352.
186. Kameda T., Mano H., Yamada Y., Takai H., Amizuka N., Kobori M., et al. Calcium-sensing receptor in mature osteoclasts, which are bone resorbing cells. Biochem Biophys Res Commun 1998, 245:419-422.
187. Kawashima H., Torikai S., Kurokawa K. Calcitonin selectively stimulates 25-hydroxyvitamin D3-1 alpha-hydroxylase in proximal straight tubule of rat kidney. Nature 1981, 291:327-329.
188. Keating F.R., Jones J.D., Elveback L.R., Randall R.V. The relation of age and sex to distribution of values in healthy adults of serum calcium, inorganic phosphorus, magnesium, alkaline phosphatase, total proteins, albumin, and blood urea. J Lab Clin Med 1969, 73:825-834.
189. Kendrick N.C., Bishop C.W., DeLuca H.F. Multiple forms of vitamin D-dependent calcium-binding protein in rat kidney. J Biol Chem 1984, 259:12691-12695.
190. Khanal R.C., Nemere I. Regulation of intestinal calcium transport. Annu Rev Nutr 2008, 28:179-196.
191. Kifor O., Moore F.D., Delaney M., Garber J., Hendy G.N., Butters R., et al. A syndrome of hypocalciuric hypercalcemia caused by autoantibodies directed at the calcium-sensing receptor. J Clin Endocrinol Metab 2003, 88:60-72.
192. 2+ flux in MDCK cells. Am J Physiol Renal Physiol 2004, 286:F363-F369.
193. Klibanski A., Arnold A.L., Toth T.L., Hornstein M.D., Neer R.M., Finkelstein J.S. Prevention of estrogen deficiency-related bone loss with human parathyroid hormone-(1-34): a randomized controlled trial. JAMA 1998, 280:1067-1073.
194. Komoto I., Kato M., Itami A., Shimada Y., Doi R., Hosotani R., et al. Expression and function of the calcium-sensing receptor in pancreatic islets and insulinoma cells. Pancreas 2003, 26:178-184.
195. Komuves L., Oda Y., Tu C.L., Chang W.H., Ho-Pao C.L., Mauro T., et al. Epidermal expression of the full-length extracellular calcium-sensing receptor is required for normal keratinocyte differentiation. J Cell Physiol 2002, 192:45-54.
196. Kragh-Hansen U., Vorum H. Quantitative analyses of the interaction between calcium ions and human serum albumin. Clin Chem 1993, 39:202-208.
197. Kremer R., Goltzman D. Parathyroid hormone stimulates mammalian renal 25-hydroxyvitamin D3-1 alpha-hydroxylase in vitro. Endocrinology 1982, 110:294-296.
198. Krisinger J., Strom M., Darwish H.M., Perlman K., Smith C., DeLuca H.F. Induction of calbindin-D 9k mRNA but not calcium transport in rat intestine by 1,25-dihydroxyvitamin D3 24-homologs. J Biol Chem 1991, 266:1910-1913.
199. Kronenberg H.M., Bringhurst F.R., Segre G.V., Potts J.T. Parathyroid hormone biosynthesis and metabolism. The parathyroids: Basic and clinical concepts 1994, 125-137. Raven Press, New York. J.P. Bilezikian (Ed.).
200. Kumar R. Calcium disorders. Fluids and electrolytes 1996, 391-419. Saunders, Philadelphia. 3rd ed. J. Kokko, R. Tannen (Eds.).
201. Kumar R. Calcium transport in epithelial cells of the intestine and kidney. J Cell Biochem 1995, 57:392-398.
202. Kumar R. Metabolism of 1,25-dihydroxyvitamin D3. Physiol Rev. 1984, 64:478-504.
203. Kumar R. Vitamin D metabolism and mechanisms of calcium transport. J Am Soc Nephrol 1990, 1:30-42.
204. Kumar R., Cohen W.R., Epstein F.H. Vitamin D and calcium hormones in pregnancy. N Engl J Med 1980, 302:1143-1145.
205. Kumar R., Cohen W.R., Silva P., Epstein F.H. Elevated 1,25-dihydroxyvitamin D plasma levels in normal human pregnancy and lactation. J Clin Invest 1979, 63:342-344.
206. Kumar R., Merimee T.J., Silva P., Epstein F.H. The effect of chronic growth hormone excess or deiciency on plasma 1,25-dihydroxyvitamin D levels in man. Proceedings of the fourth workshop on vitamin D 1979, 1005-1009. de Gruyter, Elmsford, New York. A.W. Norman, K. Schaefer, D. von Herrath, H.G. Grigoleit, J.W. Coburn, H.F. De Luca, E.B. Mawer, T. Suda (Eds.).
207. Kumar R., Riggs B.L. Vitamin D in the therapy of disorders of calcium and phosphorus metabolism. Mayo Clin Proc 1981, 56:327-333.
208. Kumar R., Schaefer J., Grande J.P., Roche P.C. Immunolocalization of calcitriol receptor, 24-hydroxylase cytochrome P-450, and calbindin D28k in human kidney. Am J Physiol 1994, 266:F477-F485.
209. Lagunova Z., Porojnicu A.C., Lindberg F., Hexeberg S., Moan J. The dependency of vitamin D status on body mass index, gender, age and season. Anticancer Res 2009, 29:3713-3720.
210. Lajeunesse D., Bouhtiauy I., Brunette M.G. Parathyroid hormone and hydrochlorothiazide increase calcium transport by the luminal membrane of rabbit distal nephron segments through different pathways. Endocrinology 1994, 134:35-41.
211. Langub M.C., Monier-Faugere M.C., Qi Q., Geng Z., Koszewski N.J., Malluche H.H. Parathyroid hormone type 1 receptor and human osteoclasts.[comment]. J Bone Miner Res 2001, 16:448-456.
212. Lawson D.E., Fraser D.R., Kodicek E., Morris H.R., Williams D.H. Identification of 1,25-dihydroxycholecalciferol, a new kidney hormone controlling calcium metabolism. Nature 1971, 230:228-230.
213. Lee G.S., Choi K.C., Park S.M., An B.S., Cho M.C., Jeung E.B. Expression of human Calbindin-D(9k) correlated with age, vitamin D receptor and blood calcium level in the gastrointestinal tissues. Clin Biochem 2003, 36:255-261.
214. Lee K., Brown D., Urena P., Ardaillou N., Ardaillou R., Deeds J., et al. Localization of parathyroid hormone/parathyroid hormone-related peptide receptor mRNA in kidney. Am J Physiol 1996, 270:F186-F191.
215. Lee S.K., Goldring S.R., Lorenzo J.A. Expression of the calcitonin receptor in bone marrow cell cultures and in bone: a specific marker of the differentiated osteoclast that is regulated by calcitonin. Endocrinology 1995, 136:4572-4581.
216. Lerner U.H., Ransjo M., Klaushofer K., Horandner H., Hoffmann O., Czerwenka E., et al. Comparison between the effects of forskolin and calcitonin on bone resorption and osteoclast morphology in vitro. Bone 1989, 10:377-387.
217. Lienhardt A., Bai M., Lagarde J.P., Rigaud M., Zhang Z., Jiang Y., et al. Activating mutations of the calcium-sensing receptor: management of hypocalcemia. J Clin Endocrinol Metab 2001, 86:5313-5323.
218. Lietman S.A., Tenenbaum-Rakover Y., Jap T.S., Yi-Chi W., De-Ming Y., Ding C., et al. A novel loss-of-function mutation, Gln459Arg, of the calcium-sensing receptor gene associated with apparent autosomal recessive inheritance of familial hypocalciuric hypercalcemia. J Clin Endocrinol Metab 2009, 94:4372-4379.
219. Liu B.A., Gordon M., Labranche J.M., Murray T.M., Vieth R., Shear N.H. Seasonal prevalence of vitamin D deficiency in institutionalized older adults. J Am Geriatr Soc 1997, 45:598-603.
220. Loffing J., Loffing-Cueni D., Valderrabano V., Klausli L., Hebert S.C., Rossier B.C., et al. Distribution of transcellular calcium and sodium transport pathways along mouse distal nephron. Am J Physiol Renal Physiol 2001, 281:F1021-F1027.
221. Lopez I., Rodriguez M., Felsenfeld A.J., Estepa J.C., Aguilera-Tejero E. Direct suppressive effect of acute metabolic and respiratory alkalosis on parathyroid hormone secretion in the dog. J Bone Miner Res 2003, 18:1478-1485.
222. Lowery W.D., Thomas C.G., Awbrey B.J., Rosenstein B.D., Talmage R.V. The late effect of subtotal thyroidectomy and radioactive iodine therapy on calcitonin secretion and bone mineral density in women treated for Graves' disease. Surgery 1986, 100:1142-1149.
223. Lund B., Sorensen O.H., Bishop J.E., Norman A.W. Stimulation of 1,25-dihydroxyvitamin D production by parathyroid hormone and hypocalcemia in man. J Clin Endocrinol Metab 1980, 50:480-484.
224. Madhok T.C., DeLuca H.F. Characteristics of the rat liver microsomal enzyme system converting cholecalciferol into 25-hydroxycholecalciferol. Evidence for the participation of cytochrome p-450. Biochem J 1979, 184:491-499.
225. Madhok T.C., Schnoes H.K., DeLuca H.F. Incorportion of oxygen-18 into the 25-position of cholecalciferol by hepatic cholecalciferol 25-hydroxylase. Biochem J 1978, 175:479-482.
226. 2+ exchanger expression in distal convoluted tubule cells. Am J Physiol Renal Physiol 2002, 283:F29-F40.
227. Mahaffee D.D., Cooper C.W., Ramp W.K., Ontjes D.A. Magnesium promotes both parathyroid hormone secretion and adenosine 3',5'-monophosphate production in rat parathyroid tissues and reverses the inhibitory effects of calcium on adenylate cyclase. Endocrinology 1982, 110:487-495.
228. Mathias R.S., Mathews C.H., Machule C., Gao D., Li W., Denbesten P.K. Identification of the calcium-sensing receptor in the developing tooth organ. J Bone Miner Res 2001, 16:2238-2244.
229. Matsuoka L.Y., Wortsman J., Haddad J.G., Hollis B.W. In vivo threshold for cutaneous synthesis of vitamin D3. J Lab Clin Med 1989, 114:301-305.
230. Matusiak D., Murillo G., Carroll R.E., Mehta R.G., Benya R.V. Expression of vitamin D receptor and 25-hydroxyvitamin D3-1(alpha)-hydroxylase in normal and malignant human colon. Cancer Epidemiol Biomarkers Prev 2005, 14:2370-2376.
231. Mayer G.P., Hurst J.G. Comparison of the effects of calcium and magnesium on parathyroid hormone secretion rate in calves. Endocrinology 1978, 102:1803-1814.
232. Mayer G.P., Hurst J.G. Sigmoidal relationship between parathyroid hormone secretion rate and plasma calcium concentration in calves. Endocrinology 1978, 102:1036-1042.
233. McElduff A., LeBoff M.S., Moore F.D., Butters R., Gao P., Cantor T.L., et al. Activating antibodies to the calcium-sensing receptor in two patients with autoimmune hypoparathyroidism. J Clin Endocrinol Metab 2004, 89:548-556.
234. McKinney K., Breitkopf C.R., Berenson A.B. Association of race, body fat and season with vitamin D status among young women: a cross-sectional study. Clin Endocrinol (Oxf) 2008, 69:535-541.
235. McNeil L., Hobson S., Nipper V., Rodland K.D. Functional calcium-sensing receptor expression in ovarian surface epithelial cells. Am J Obstet Gynecol 1998, 178:305-313.
236. McNeil S.E., Hobson S.A., Nipper V., Rodland K.D. Functional calcium-sensing receptors in rat fibroblasts are required for activation of SRC kinase and mitogen-activated protein kinase in response to extracellular calcium. J Biol Chem 1998, 273:1114-1120.
237. Mehrotra M., Gupta S.K., Tiwari S., Agarwal A., Kumar K., Awasthi P.K., et al. Effect of oophorectomy on expression of calcium sensing receptor mRNA in rat duodenal mucosa. Indian J Exp Biol 2003, 41:41-46.
238. Menaa C., Vrtovsnik F., Friedlander G., Corvol M., Garabedian M. Insulin-like growth factor I, a unique calcium-dependent stimulator of 1,25-dihydroxyvitamin D3 production. Studies in cultured mouse kidney cells. J Biol Chem 1995, 270:25461-25467.
239. Mirzaei S., Krotla G., Knoll P., Koriska K., Kohn H. Possible effect of calcitonin deficiency on bone mass after subtotal thyroidectomy. Acta Med Austriaca 1999, 26:29-31.
240. Miyashiro K., Kunii I., Manna T.D., de Menezes Filho H.C., Damiani D., Setian N., et al. Severe hypercalcemia in a 9-year-old Brazilian girl due to a novel inactivating mutation of the calcium-sensing receptor. J Clin Endocrinol Metab 2004, 89:5936-5941.
241. Moore E.W. Ionized calcium in normal serum, ultrafiltrates, and whole blood determined by ion-exchange electrodes. J Clin Invest 1970, 49:318-334.
242. Moore P.R., Mawer E.B., Houghton D., Freemont A.J., Hutchison A.J., Gokal R., et al. Down-regulation of human osteoblast PTH/PTHrP receptor mRNA in end-stage renal failure. Kidney Int 2000, 58:1440-1449.
243. 2+ channel (ECAC1). Genomics 2000, 67:48-53.
244. Muller D., Hoenderop J.G., Merkx G.F., van Os C.H., Bindels R.J. Gene structure and chromosomal mapping of human epithelial calcium channel. Biochem Biophys Res Commun 2000, 275:47-52.
245. Murayama A., Takeyama K., Kitanaka S., Kodera Y., Kawaguchi Y., Hosoya T., et al. Positive and negative regulations of the renal 25-hydroxyvitamin D3 1alpha-hydroxylase gene by parathyroid hormone, calcitonin, and 1alpha,25(OH)2D3 in intact animals. Endocrinology 1999, 140:2224-2231.
246. Myrtle J.F., Haussler M.R., Norman AW. Evidence for the biologically active form of cholecalciferol in the intestine. J Biol Chem 1970, 245:1190-1196.
247. Nakajima K., Yamazaki K., Kimura H., Takano K., Miyoshi H., Sato K. Novel gain of function mutations of the calcium-sensing receptor in two patients with PTH-deficient hypocalcemia. Intern Med 2009, 48:1951-1956.
248. Navarro J.F., Mora C., Macia M., Garcia J. Serum magnesium concentration is an independent predictor of parathyroid hormone levels in peritoneal dialysis patients. Perit Dial Int 1999, 19:455-461.
249. Naveh-Many T., Marx R., Keshet E., Pike J.W., Silver J. Regulation of 1,25-dihydroxyvitamin D3 receptor gene expression by 1,25-dihydroxyvitamin D3 in the parathyroid in vivo. J Clin Invest 1990, 86:1968-1975.
250. Neer R.M., Arnaud C.D., Zanchetta J.R., Prince R.L., Gaich G.A., Reginster J.Y., et al. Effect of parathyroid hormone (1-34) on fractures and bone mineral density in postmenopausal women with osteoporosis. N Engl J Med 2001, 344:1434-1441.
251. 2+ channel TRPV6 in the kidney. J Am Soc Nephrol 2003, 14:2731-2740.
252. Nishikawa T., Ishikawa H., Yamamoto S., Koshihara Y. A novel calcitonin receptor gene in human osteoclasts from normal bone marrow. FEBS Lett 1999, 458:409-414.
253. Nissen P.H., Christensen S.E., Heickendorff L., Brixen K., Mosekilde L. Molecular genetic analysis of the calcium sensing receptor gene in patients clinically suspected to have familial hypocalciuric hypercalcemia: phenotypic variation and mutation spectrum in a Danish population. J Clin Endocrinol Metab 2007, 92:4373-4379.
254. Nomura R., Sugimoto T., Tsukamoto T., Yamauchi M., Sowa H., Chen Q., et al. Marked and sustained increase in bone mineral density after parathyroidectomy in patients with primary hyperparathyroidism; a six-year longitudinal study with or without parathyroidectomy in a Japanese population. Clin Endocrinol (Oxf) 2004, 60:335-342.
255. Nordenstrom E., Westerdahl J., Bergenfelz A. Recovery of bone mineral density in 126 patients after surgery for primary hyperparathyroidism. World J Surg 2004, 28:502-507.
256. Norman D.A., Fordtran J.S., Brinkley L.J., Zerwekh J.E., Nicar M.J., Strowig S.M., et al. Jejunal and ileal adaptation to alterations in dietary calcium: changes in calcium and magnesium absorption and pathogenetic role of parathyroid hormone and 1,25-dihydroxyvitamin D. J Clin Invest 1981, 67:1599-1603.
257. Okamoto Y., DeLuca H.F. Separation of two forms of chick 1,25-dihydroxyvitamin D3 and 25-hydroxyvitamin D3 24-hydroxylase. Proc Soc Exp Biol Med 1994, 205:52-55.
258. Okano T., Tsugawa N., Morishita A., Kato S. Regulation of gene expression of epithelial calcium channels in intestine and kidney of mice by 1alpha,25-dihydroxyvitamin D3. J Steroid Biochem Mol Biol 2004, 89-90:335-338.
259. Okazaki T., Igarashi T., Kronenberg H.M. 5'-flanking region of the parathyroid hormone gene mediates negative regulation by 1,25-(OH)2 vitamin D3. J Biol Chem 1988, 263:2203-2208.
260. Omdahl J., Holick M., Suda T., Tanaka Y., DeLuca H.F. Biological activity of 1,25-dihydroxycholecalciferol. Biochemistry (Mosc) 1971, 10:2935-2940.
261. Omdahl J.L. Interaction of the parathyroid and 1,25-dihydroxyvitamin D3 in the control of renal 25-hydroxyvitamin D3 metabolism. J Biol Chem 1978, 253:8474-8478.
262. Omdahl J.L., Gray R.W., Boyle I.T., Knutson J., DeLuca H.F. Regulation of metabolism of 25-hydroxycholecalciferol by kidney tissue in vitro by dietary calcium. Nature New Biol 1972, 237:63-64.
263. Orrell D.H. Albumin as an aid to the interpretation of serum calcium. Clin Chim Acta 1971, 35:483-489.
264. Orwoll E., Kane-Johnson N., Cook J., Roberts L., Strasik L., McClung M. Acute parathyroid hormone secretory dynamics: hormone secretion from normal primate and adenomatous human tissue in response to changes in extracellular calcium concentration. J Clin Endocrinol Metab 1986, 62:950-955.
265. Pahuja D.N., De Luca H.F. Thyroid hormone and vitamin D metabolism in the rat. Arch Biochem Biophys 1982, 213:293-298.
266. Pallais J.C. Acquired hypocalciuric hypercalcemia due to autoantibodies against the calcium-sensing receptor. N Engl J Med 2004, 351:362-369.
267. Palmer G., Bonjour J.P., Rizzoli R., Manen D. Positive and negative control of the expression of parathyroid hormone (PTH)/PTH-related protein receptor via proximal promoter P3 in human osteoblast-like cells. J Clin Endocrinol Metab 2000, 85:3376-3382.
268. Palmer G., Bonjour J.P., Rizzoli R., Manen D. Sequence and activity of parathyroid hormone/parathyroid hormone-related protein receptor promoter region in human osteoblast-like cells. Gene 1998, 218:49-56.
269. Pannabecker T.L., Chandler J.S., Wasserman R.H. Vitamin-D-dependent transcriptional regulation of the intestinal plasma membrane calcium pump. Biochem Biophys Res Commun 1995, 213:499-505.
270. Pedersen J.I., Ghazarian J.G., Orme-Johnson N.R., DeLuca H.F. Isolation of chick renal mitochondrial ferredoxin active in the 25-hydroxyvitamin D3-1alpha-hydroxylase system. J Biol Chem 1976, 251:3933-3941.
271. Peng J.B., Hediger M.A. A family of calcium-permeable channels in the kidney: distinct roles in renal calcium handling. Curr Opin Nephrol Hypertens 2002, 11:555-561.
272. Perez Jurado L.A., Li X., Francke U. The human calcitonin receptor gene (CALCR) at 7q21.3 is outside the deletion associated with the Williams syndrome. Cytogenet Cell Genet 1995, 70:246-249.
273. Perwad F., Zhang M.Y., Tenenhouse H.S., Portale A.A. Fibroblast growth factor 23 impairs phosphorus and vitamin D metabolism in vivo and suppresses 25-hydroxyvitamin D-1alpha-hydroxylase expression in vitro. Am J Physiol Renal Physiol 2007, 293:F1577-F1583.
274. Pidasheva S., D'Souza-Li L., Canaff L., Cole D.E., Hendy G.N. CASRdb: calcium-sensing receptor locus-specific database for mutations causing familial (benign) hypocalciuric hypercalcemia, neonatal severe hyperparathyroidism, and autosomal dominant hypocalcemia. Hum Mutat 2004, 24:107-111.
275. Pike J.W., Parker J.B., Haussler M.R., Boass A., Toverud S.V. Dynamic changes in circulating 1,25-dihydroxyvitamin D during reproduction in rats. Science 1979, 204:1427-1429.
276. Ponchon G., DeLuca H.F. Metabolism and biological activity of vitamin D. Calcif Tissue Res 1970, (Suppl):43-44.
277. Ponchon G., Deluca H.F. Metabolites of vitamin D3 and their biologic activity. J Nutr 1969, 99:157-167.
278. Ponchon G., DeLuca H.F. The role of the liver in the metabolism of vitamin D. J Clin Invest 1969, 48:1273-1279.
279. Ponchon G., Kennan A.L., DeLuca H.F. Activation" of vitamin D by the liver. J Clin Invest 1969, 48:2032-2037.
280. Popken J.L., Brooks R.A., Foy R.B. Atomic absorption analysis of selected metals associated with serum protein fractions. Am J Med Technol 1974, 40:260-264.
281. Poskitt E.M., Cole T.J., Lawson DE. Diet, sunlight, and 25-hydroxy vitamin D in healthy children and adults. Br Med J 1979, 1:221-223.
282. Prosser D.E., Jones G. Enzymes involved in the activation and inactivation of vitamin D. Trends Biochem Sci 2004, 29:664-673.
283. Przepiorka D., Baylin S.B., McBride O.W., Testa J.R., de Bustros A., Nelkin B.D. The human calcitonin gene is located on the short arm of chromosome 11. Biochem Biophys Res Commun 1984, 120:493-499.
284. Quarles L.D. Extracellular calcium-sensing receptors in the parathyroid gland, kidney, and other tissues. Curr Opin Nephrol Hypertens 2003, 12:349-355.
285. Raisz L.G., Trummel C.L., Holick M.F., DeLuca H.F. 1,25-dihydroxycholecalciferol: a potent stimulator of bone resorption in tissue culture. Science 1972, 175:768-769.
286. Rakopoulos M., Ikegame M., Findlay D.M., Martin T.J., Moseley J.M. Short treatment of osteoclasts in bone marrow culture with calcitonin causes prolonged suppression of calcitonin receptor mRNA. Bone 1995, 17:447-453.
287. Raman A. The calcium fractions of normal serum. Clin Biochem 1971, 4:141-146.
288. Ramirez J.A., Goodman W.G., Gornbein J., Menezes C., Moulton L., Segre G.V., et al. Direct in vivo comparison of calcium-regulated parathyroid hormone secretion in normal volunteers and patients with secondary hyperparathyroidism. J Clin Endocrinol Metab 1993, 76:1489-1494.
289. Rasmussen H., Wong M., Bikle D., Goodman D.B. Hormonal control of the renal conversion of 25-hydroxycholecalciferol to 1,25-dihydroxycholecalciferol. J Clin Invest 1972, 51:2502-2504.
290. Rasschaert J., Malaisse W.J. Expression of the calcium-sensing receptor in pancreatic islet B-cells. Biochem Biophys Res Commun 1999, 264:615-618.
291. Riccardi D., Brown E.M. Physiology and pathophysiology of the calcium-sensing receptor in the kidney. Am J Physiol Renal Physiol 2010, 298:F485-F499.
292. 2+-sensing receptor and PTH/PTHrP receptor in rat kidney. Am J Physiol 1996, 271:F951-F956.
293. Rost C.R., Bikle D.D., Kaplan R.A. In vitro stimulation of 25-hydroxycholecalciferol 1 alpha-hydroxylation by parathyroid hormone in chick kidney slices: evidence for a role for adenosine 3',5'-monophosphate. Endocrinology 1981, 108:1002-1006.
294. Rude R.K., Oldham S.B., Sharp C.F., Singer F.R. Parathyroid hormone secretion in magnesium deficiency. J Clin Endocrinol Metab 1978, 47:800-806.
295. Russell J., Ashok S., Koszewski N.J. Vitamin D receptor interactions with the rat parathyroid hormone gene: synergistic effects between two negative vitamin D response elements. J Bone Miner Res 1999, 14:1828-1837.
296. +-dependent phosphate co-transport activity and 1alpha,25-dihydroxyvitamin D3 production. J Biol Chem 2003, 278:2206-2211.
297. Sakaki T., Kagawa N., Yamamoto K., Inouye K. Metabolism of vitamin D3 by cytochromes P450. Front Biosci 2005, 10:119-134.
298. Sauveur B., Garabedian M., Fellot C., Mongin P., Balsan S. The effect of induced metabolic acidosis on vitamin D3 metabolism in rachitic chicks. Calcif Tissue Res 1977, 23:121-124.
299. 3 by human CYP27A1. Biochem Biophys Res Commun 2000, 273:977-984.
300. Sawers J.S., Kellett H.A., Brown N.S., Beckett G.J., Seth J., Sinclair I.S., et al. Does calcitonin cause hypocalcaemia after thyroidectomy?. Br J Surg 1982, 69:456-458.
301. Schiavi S.C., Kumar R. The phosphatonin pathway: new insights in phosphate homeostasis. Kidney Int 2004, 65:1-14.
302. Schipani E., Karga H., Karaplis A.C., Potts J.T., Kronenberg H.M., Segre G.V., et al. Identical complementary deoxyribonucleic acids encode a human renal and bone parathyroid hormone (PTH)/PTH-related peptide receptor. Endocrinology 1993, 132:2157-2165.
303. 3-hydroxylases. Steroids 2001, 66:399-408.
304. Schuster I., Egger H., Bikle D., Herzig G., Reddy G.S., Stuetz A., et al. Selective inhibition of vitamin D hydroxylases in human keratinocytes. Steroids 2001, 66:409-422.
305. Seeman E., Kumar R., Hunder G.G., Scott M., Heath H., Riggs B.L. Production, degradation, and circulating levels of 1,25-dihydroxyvitamin D in health and in chronic glucocorticoid excess. J Clin Inves.t 1980, 66:664-669.
306. Sherwood L.M., Herrman I., Bassett C.A. Parathyroid hormone secretion in vitro: regulation by calcium and magnesium ions. Nature 1970, 225:1056-1058.
307. Sherwood L.M., Mayer G.P., Ramberg C.F., Kronfeld D.S., Aurbach G.D., Potts J.T. Regulation of parathyroid hormone secretion: proportional control by calcium, lack of effect of phosphate. Endocrinology 1968, 83:1043-1051.
308. Shimada T., Hasegawa H., Yamazaki Y., Muto T., Hino R., Takeuchi Y., et al. FGF-23 is a potent regulator of vitamin D metabolism and phosphate homeostasis. J Bone Miner Res 2004, 19:429-435.
309. Shimada T., Kakitani M., Yamazaki Y., Hasegawa H., Takeuchi Y., Fujita T., et al. Targeted ablation of Fgf23 demonstrates an essential physiological role of FGF23 in phosphate and vitamin D metabolism. J Clin Invest 2004, 113:561-568.
310. Shimada T., Mizutani S., Muto T., Yoneya T., Hino R., Takeda S., et al. Cloning and characterization of FGF23 as a causative factor of tumor-induced osteomalacia. Proc Natl Acad Sci USA 2001, 98:6500-6505.
311. Shimizu T., Yoshitomi K., Nakamura M., Imai M. Effects of PTH, calcitonin, and cAMP on calcium transport in rabbit distal nephron segments. Am J Physiol 1990, 259:F408-F414.
312. 3-1alpha-hydroxylase gene in normocalcemic rats. Proc Natl Acad Sci USA 1999, 96:8253-8258.
313. Shinkyo R., Sakaki T., Kamakura M., Ohta M., Inouye K. Metabolism of vitamin D by human microsomal CYP2R1. Biochem Biophys Res Commun 2004, 324:451-457.
314. Shiohara M., Mori T., Mei B., Brown E.M., Watanabe T., Yasuda T. A novel gain-of-function mutation (F821L) in the transmembrane domain of calcium-sensing receptor is a cause of severe sporadic hypoparathyroidism. Eur J Pediatr 2004, 163:94-98.
315. Silver J., Naveh-Many T., Mayer H., Schmelzer H.J., Popovtzer M.M. Regulation by vitamin D metabolites of parathyroid hormone gene transcription in vivo in the rat. J Clin Invest 1986, 78:1296-1301.
316. Silver J., Russell J., Sherwood L.M. Regulation by vitamin D metabolites of messenger ribonucleic acid for preproparathyroid hormone in isolated bovine parathyroid cells. Proc Natl Acad Sci USA 1985, 82:4270-4273.
317. 3-1alpha hydroxylase expression and activity in cultured human osteoblasts and their modulation by parathyroid hormone, estrogenic compounds and dihydrotestosterone. J Steroid Biochem Mol Biol 2007, 107:238-244.
318. 3-1alpha-hydroxylase is expressed in human vascular smooth muscle cells and is upregulated by parathyroid hormone and estrogenic compounds. Circulation 2005, 111:1666-1671.
319. Sommer S., Berndt T., Craig T., Kumar R. The phosphatonins and the regulation of phosphate transport and vitamin D metabolism. J Steroid Biochem Mol Biol 2007, 103:497-503.
320. Song Y., Kato S., Fleet J.C. Vitamin D receptor (VDR) knockout mice reveal VDR-independent regulation of intestinal calcium absorption and ECaC2 and calbindin D9k mRNA. J Nutr 2003, 133:374-380.
321. Spanos E., Colston K.W., Evans I.M., Galante L.S., Macauley S.J., Macintyre I. Effect of prolactin on vitamin D metabolism. Mol Cell Endocrinol 1976, 5:163-167.
322. Speer G., Toth M., Niller H.H., Salamon D., Takacs I., Miheller P., et al. Calcium metabolism and endocrine functions in a family with familial hypocalciuric hypercalcemia. Exp Clin Endocrinol Diabetes 2003, 111:486-490.
323. St-Arnaud R., Messerlian S., Moir J.M., Omdahl J.L., Glorieux F.H. The 25-hydroxyvitamin D 1-alpha-hydroxylase gene maps to the pseudovitamin D-deficiency rickets (PDDR) disease locus. J Bone Miner Res 1997, 12:1552-1559.
324. 2+ pump. A study using specific antibodies. J Biol Chem 1995, 270:12184-12190.
325. Staun M., Paerregaard A., Krasilnikoff P.A. Measurement of calbindin-D9K in small intestinal biopsy specimens of children. J Pediatr Gastroenterol Nutr 1991, 12:328-331.
326. Steenbock H., Black A. Fact-soluble vitamins. XVII. The induction of growth-promoting and calcifying properties in a ration by exposure to ultraviolet light. J Biol Chem 1924, 61:405-422.
327. Steenbock H., Hart E. The influence of function on the lime requirements of animals. J Biol Chem 1913, 14:1913.
328. Stellinga-Boelen A.A., Wiegersma P.A., Storm H., Bijleveld C.M., Verkade H.J. Vitamin D levels in children of asylum seekers in the Netherlands in relation to season and dietary intake. Eur J Pediatr 2007, 166:201-206.
329. Suda T., DeLuca H.F., Schnoes H., Blunt J.W. 25-hydroxyergocalciferol: a biologically active metabolite of vitamin D2. Biochem Biophys Res Commun 1969, 35:182-185.
330. Suda T., DeLuca H.F., Schnoes H.K., Blunt J.W. The isolation and identification of 25-hydroxyergocalciferol. Biochemistry (Mosc) 1969, 8:3515-3520.
331. Suda T., Takahashi N., Udagawa N., Jimi E., Gillespie M.T., Martin T.J. Modulation of osteoclast differentiation and function by the new members of the tumor necrosis factor receptor and ligand families. Endocr Rev 1999, 20:345-357.
332. 3 in osteoclast-like multinucleated cells formed from mouse bone marrow cells. Endocrinology 1988, 123:1504-1510.
333. Takatsuki K., Hanley D.A., Sherwood L.M. Effects of magnesium ion on parathyroid hormone secretion in vitro. Calcif Tissue Int 1980, 32:201-206.
334. Tanaka Y., Castillo L., DeLuca H.F. Control of renal vitamin D hydroxylases in birds by sex hormones. Proc Natl Acad Sci USA 1976,
335. Tanaka Y., Deluca H.F. The control of 25-hydroxyvitamin D metabolism by inorganic phosphorus. Arch Biochem Biophys 1973, 154:566-574.
336. Tanaka Y., DeLuca H.F., Omdahl J., Holick M.F. Mechanism of action of 1,25-dihydroxycholecalciferol on intestinal calcium transport. Proc Natl Acad Sci USA 1971, 68:1286-1288.
337. Targovnik J.H., Rodman J.S., Sherwood L.M. Regulation of parathyroid hormone secretion in vitro: quantitative aspects of calcium and magnesium ion control. Endocrinology 1971, 88:1477-1482.
338. Tauc M., Bidet M., Poujeol P. Chloride currents activated by calcitonin and cAMP in primary cultures of rabbit distal convoluted tubule. J Membr Biol 1996, 150:255-273.
339. Tebben P.J., Kumar R. Vitamin D and the kidney. Vitamin D 2005, 515-536. Academic Press, Burlington, MA. 2nd ed. D. Feldman, J.W. Pike, F.H. Glorieux (Eds.).
340. Teegarden D., Meredith S.C., Sitrin M.D. Determination of the affinity of vitamin D metabolites to serum vitamin D binding protein using assay employing lipid-coated polystyrene beads. Anal Biochem 1991, 199:293-299.
341. Thode J., Juul-Jorgensen B., Bhatia H.M., Kjaerulf-Nielsen M., Bartels P.D., Fogh-Andersen N., et al. Comparison of serum total calcium, albumin-corrected total calcium, and ionized calcium in 1213 patients with suspected calcium disorders. Scand J Clin Lab Invest 1989, 49:217-223.
342. Tian J., Smogorzewski M., Kedes L., Massry S.G. Parathyroid hormone-parathyroid hormone related protein receptor messenger RNA is present in many tissues besides the kidney. Am J Nephrol 1993, 13:210-213.
343. Tian J., Smogorzewski M., Kedes L., Massry S.G. PTH-PTHrP receptor mRNA is downregulated in chronic renal failure. Am J Nephrol 1994, 14:41-46.
344. Tikellis C., Xuereb L., Casley D., Brasier G., Cooper M.E., Wookey P.J. Calcitonin receptor isoforms expressed in the developing rat kidney. Kidney Int 2003, 63:416-426.
345. Tjellesen L., Christiansen C. Vitamin D metabolites in normal subjects during one year. A longitudinal study. Scand J Clin Lab Invest 1983, 43:85-89.
346. Tolcos M., Tikellis C., Rees S., Cooper M., Wookey P. Ontogeny of calcitonin receptor mRNA and protein in the developing central nervous system of the rat. J Comp Neurol 2003, 456:29-38.
347. 2+ pump from proximal kidney tubules is exclusively localized and active in caveolae. FEBS Lett 2004, 576:31-35.
348. 3 in primary cultures of chick kidney cells. J Clin Invest 1979, 64:206-217.
349. Trummel C.L., Raisz L.G., Blunt J.W., Deluca H.F. 25-Hydroxycholecalciferol: stimulation of bone resorption in tissue culture. Science 1969, 163:1450-1451.
350. Tsai K.S., Wahner H.W., Offord K.P., Melton L.J., Kumar R., Riggs B.L. Effect of aging on vitamin D stores and bone density in women. Calcif Tissue Int 1987, 40:241-243.
351. Tsurukai T., Udagawa N., Matsuzaki K., Takahashi N., Suda T. Roles of macrophage-colony stimulating factor and osteoclast differentiation factor in osteoclastogenesis. J Bone Miner Metab 2000, 18:177-184.
352. Turner R.L. Mammalian 25-hydroxyvitamin D 1-a-hydroxylase: measurement and regulation. Vitamin D: Basic and clinical aspects 1984, 175-196. Nijhoff, Boston. R. Kumar (Ed.).
353. Urena P., Kong X.F., Abou-Samra A.B., Juppner H., Kronenberg H.M., Potts J.T., et al. Parathyroid hormone (PTH)/PTH-related peptide receptor messenger ribonucleic acids are widely distributed in rat tissues. Endocrinology 1993, 133:617-623.
354. Urena P., Kubrusly M., Mannstadt M., Hruby M., Trinh M.M., Silve C., et al. The renal PTH/PTHrP receptor is down-regulated in rats with chronic renal failure. Kidney Int 1994, 45:605-611.
355. Urist M.R. Fundamental and clinical bone physiology 1980, J. B. Lippincott, Philadelphia.
356. 2+ channels in small intestine as studied by quantitative mRNA detection. Am J Physiol Gastrointest Liver Physiol 2003, 285:G78-G85.
357. Van Cromphaut S.J., Dewerchin M., Hoenderop J.G., Stockmans I., Van Herck E., Kato S., et al. Duodenal calcium absorption in vitamin D receptor-knockout mice: functional and molecular aspects. Proc Natl Acad Sci USA 2001, 98:13324-13329.
358. Varghese Z., Fernando R., Powas S.H., Moorhead J.F., Varghese S. Analysis of rat vitamin D-dependent calbindin-D28k gene expression. Clin Nephrol 1999, 51:263-271.
359. Wada S., Udagawa N., Nagata N., Martin T.J., Findlay D.M. Physiological levels of calcitonin regulate the mouse osteoclast calcitonin receptor by a protein kinase Alpha-mediated mechanism. Endocrinology 1996, 137:312-320.
360. Ward B.K., Magno A.L., Davis E.A., Hanyaloglu A.C., Stuckey B.G., Burrows M., et al. Functional deletion of the calcium-sensing receptor in a case of neonatal severe hyperparathyroidism. J Clin Endocrinol Metab 2004, 89:3721-3730.
361. Wasserman R.H., Chandler J.S., Meyer S.A., Smith C.A., Brindak M.E., Fullmer C.S., et al. Intestinal calcium transport and calcium extrusion processes at the basolateral membrane. J Nutr 1992, 122:662-671.
362. Wasserman R.H., Fulmer C.S., Shimura F. Calcium absorption and the molecular effects of vitamin D 3. Vitamin D: Basic and clinical aspects 1984, 233-302. Nijhoff, Boston. R. Kumar (Ed.).
363. Wasserman R.H., Smith C.A., Brindak M.E., De Talamoni N., Fullmer C.S., Penniston J.T., et al. Vitamin D and mineral deficiencies increase the plasma membrane calcium pump of chicken intestine. Gastroenterology 1992, 102:886-894.
364. Watson C.G., Steed D.L., Robinson A.G., Deftos L.J. The role of calcitonin and parathyroid hormone in the pathogenesis of post-thyroidectomy hypocalcemia. Metabolism 1981, 30:588-589.
365. Weber H.P., Gray R.W., Dominguez J.H., Lemann J. The lack of effect of chronic metabolic acidosis on 25-OH-vitamin D metabolism and serum parathyroid hormone in humans. J Clin Endocrinol Metab 1976, 43:1047-1055.
366. Weber K., Erben R.G., Rump A., Adamski J. Gene structure and regulation of the murine epithelial calcium channels ECaC1 and 2. Biochem Biophys Res Commun 2001, 289:1287-1294.
367. White P., Cooke N. The multifunctional properties and characteristics of vitamin D-binding protein. Trends Endocrinol Metab 2000, 11:320-327.
368. Wilkins R. Absorption of calcium, phosphorus and magnesium 1976, Churchill Livingstone, New York.
369. Windaus A., Linsert O., Luttringhaus A., Weidlich G. Crystalline-vitamin D 2. Annalen de Chemie 1932, 492:226-241.
370. Windaus A., Schenck F., von Weder F. Uber das antirachitisch wirksame bestrahlungs-produkt aus 7-dehydro-cholesterin. Hoppe-Selyers Z Physiol Chem 1936, 241:100-103.
371. Wongsurawat N., Armbrecht H.J. Calcitonin stimulates 1,25-dihydroxyvitamin D production in diabetic rat kidney. Metabolism 1991, 40:22-25.
372. Yamaguchi T., Chattopadhyay N., Kifor O., Ye C., Vassilev P.M., Sanders J.L., et al. Expression of extracellular calcium-sensing receptor in human osteoblastic MG-63 cell line. Am J Physiol Cell Physiol 2001, 280:C382-C393.
373. Yamasaki T., Izumi S., Ide H., Ohyama Y. Identification of a novel rat microsomal vitamin D3 25-hydroxylase. J Biol Chem 2004, 279:22848-22856.
374. Yamauchi M., Sugimoto T., Yamaguchi T., Yano S., Wang J., Bai M., et al. Familial hypocalciuric hypercalcemia caused by an R648stop mutation in the calcium-sensing receptor gene. J Bone Miner Res 2002, 17:2174-2182.
375. 2+-sensing receptor mRNAs along the rat nephron. Am J Physiol 1997, 272:F751-F758.
376. Yano S., Brown E.M., Chattopadhyay N. Calcium-sensing receptor in the brain. Cell Calcium 2004, 35:257-264.
377. Yano S., Sugimoto T., Tsukamoto T., Chihara K., Kobayashi A., Kitazawa S., et al. Decrease in vitamin D receptor and calcium-sensing receptor in highly proliferative parathyroid adenomas. Eur J Endocrinol 2003, 148:403-411.
378. Yoon P.S., DeLuca H.F. Purification and properties of chick renal mitochondrial ferredoxin. Biochemistry (Mosc) 1980, 19:2165-2171.
379. 3-25-hydroxylase. Arch Biochem Biophys 1980, 203:529-541.
380. 3 1 alpha-hydroxylase. Characterization of the iron-sulfur cluster using interprotein cluster transfer and electron paramagnetic resonance spectroscopy. Biochemistry (Mosc) 1980, 19:2172-2176.
381. 3 1alpha-hydroxylase mRNA expression via protein kinase C pathway in LLC-PK1 cells. J Am Soc Nephrol 1999, 10:2474-2479.
382. Yoshida T., Yoshida N., Monkawa T., Hayashi M., Saruta T. Dietary phosphorus deprivation induces 25-hydroxyvitamin D(3) 1alpha-hydroxylase gene expression. Endocrinology 2001, 142:1720-1726.
383. 3-1alpha-hydroxylase in the human kidney. J Am Soc Nephrol 1999, 10:2465-2473.
384. 3 1alpha-hydroxylase expression in human placenta and decidua. Am J Pathol 2002, 161:105-114.
385. Zelinski J.M., Sykes D.E., Weiser M.M. The effect of vitamin D on rat intestinal plasma membrane CA-pump mRNA. Biochem Biophys Res Commun 1991, 179:749-755.
386. Zhang M.Y., Wang X., Wang J.T., Compagnone N.A., Mellon S.H., Olson J.L., et al. Dietary phosphorus transcriptionally regulates 25-hydroxyvitamin D-1alpha-hydroxylase gene expression in the proximal renal tubule. Endocrinology 2002, 143:587-595.
387. Zuo Q., Claveau D., Hilal G., Leclerc M., Brunette M.G. Effect of calcitonin on calcium transport by the luminal and basolateral membranes of the rabbit nephron. Kidney Int 1997, 51:1991-1999.